Search
for
Sort by
Research 901–930 of 1000+
- 808 Lichen planus single cell and spatial profiling of cutaneous lichen planus treated with baricitinib
- BH08 Evaluating quality-of-life measures for alopecia: a comparative analysis of Dermatology Life Quality Index and Hospital Anxiety and Depression Scale correlations with disease severity
- Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
- Reddit Analysis Reveals Common Questions of Patients with Alopecia Areata about JAK Inhibitors for Hair Loss.
- 1108 Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
- Paediatric Alopecia Areata: Successful Treatment and hair regrowth using Yoga Prana Vidya Healing Protocols
- Paediatric Alopecia Areata: Successful Treatment and hair regrowth using Yoga Prana Vidya Healing Protocols
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Autoinmune Alopecia/Alopecia Areata
- 43696 Early real-world experience with baricitinib in the treatment of severe alopecia areata
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Review of Promising Off-Label Use of Deucravacitinib
- Etrasimod for alopecia areata: The scenario for a less extensive and moderate form
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- Discoid lupus erythematosus successfully treated with deucravacitinib